Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients

Oral Oncology

Volumn 43, Issue 7, 2007, Pages 713-719

  Bandrés, Eva ^a   Barricarte, Rubén ^a   Cantero, Cristina ^a   Honorato, Beatriz ^a   Malumbres, Raquel ^a   Zárate, Ruth ^a   Alcalde, Juan ^b   García Foncillas, Jesús ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

EGFR; Head and neck; Overall survival; Polymorphisms

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENE SEQUENCE; GENOTYPE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 34447307912     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.09.002     Document Type: Article

References (29)

1. Davies R.L., Grosse V.A., Kucherlapati R., and Bothwell M. Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7. Proc Natl Acad Sci USA 77 7 (1980) 4188-4192
2. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., and Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284 1 (2003) 31-53
3. Klijn J.G., Berns P.M., Schmitz P.I., and Foekens J.A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev 13 1 (1992) 3-17
4. Veale D., Kerr N., Gibson G.J., Kelly P.J., and Harris A.L. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Brit J Cancer 68 1 (1993) 162-165
5. Zhang W., Park D.J., Lu B., Yang D.Y., Gordon M., Groshen S., et al. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation. Clin Cancer Res 11 2 Pt 1 (2005) 600-605
6. Wrensch M., Wiencke J.K., Wiemels J., Miike R., Patoka J., Moghadassi M., et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 66 8 (2006) 4531-4541
7. Crews K.R. Individualizing chemotherapeutic treatment of colorectal cancer. Am J Health Syst Pharm 63 9 Suppl 2 (2006) S12-S17
8. Rosell R., Cuello M., Cecere F., Santarpia M., Reguart N., Felip E., et al. Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going. Curr Opin Oncol 18 2 (2006) 135-143
9. Mrhalova M., Plzak J., Betka J., and Kodet R. Epidermal growth factor receptor-its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. Neoplasma 52 4 (2005) 338-343
10. Zimmermann M., Zouhair A., Azria D., and Ozsahin M. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol 1 1 (2006) 11
11. Amador M.L., Oppenheimer D., Perea S., Maitra A., Cusati G., Iacobuzio-Donahue C., et al. An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors. Cancer Res 64 24 (2004) 9139-9143
12. Moriai T., Kobrin M.S., Hope C., Speck L., and Korc M. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Proc Natl Acad Sci USA 91 21 (1994) 10217-10221
13. Liu W., Innocenti F., Wu M.H., Desai A.A., Dolan M.E., Cook Jr. E.H., et al. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res 65 1 (2005) 46-53
14. Mao L., Hong W.K., and Papadimitrakopoulou V.A. Focus on head and neck cancer. Cancer Cell 5 4 (2004) 311-316
15. Gupta A.K., McKenna W.G., Weber C.N., Feldman M.D., Goldsmith J.D., Mick R., et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 8 3 (2002) 885-892
16. Modjtahedi H. Molecular therapy of head and neck cancer. Cancer Metast Rev 24 1 (2005) 129-146
17. Herbst R.S., Arquette M., Shin D.M., Dicke K., Vokes E.E., Azarnia N., et al. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck. J Clin Oncol 23 24 (2005) 5578-5587
18. Baselga J., Trigo J.M., Bourhis J., Tortochaux J., Cortes-Funes H., Hitt R., et al. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 23 24 (2005) 5568-5577
19. Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 6 (2006) 567-578
20. Liu W., Innocenti F., Chen P., Das S., Cook Jr. E.H., and Ratain M.J. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res 9 3 (2003) 1009-1012
21. Shin D.M., Ro J.Y., Hong W.K., and Hittelman W.N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54 12 (1994) 3153-3159
22. Milas L., Raju U., Liao Z., and Ajani J. Targeting molecular determinants of tumor chemo-radioresistance. Semin Oncol 32 6 Suppl 9 (2005) S78-S81
23. Milas L., Fan Z., Andratschke N.H., and Ang K.K. Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies. Int J Radiat Oncol Biol Phys 58 3 (2004) 966-971
24. Sheridan M.T., O'Dwyer T., Seymour C.B., and Mothersill C.E. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiat Oncol Investig 5 4 (1997) 180-186
25. Bianco C., Tortora G., Bianco R., Caputo R., Veneziani B.M., Caputo R., et al. Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). Clin Cancer Res 8 10 (2002) 3250-3258
26. Yusoff P., Lao D.H., Ong S.H., Wong E.S., Lim J., Lo T.L., et al. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 277 5 (2002) 3195-3201
27. Gebhardt F., Zanker K.S., and Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 274 19 (1999) 13176-13180
28. Buerger H., Gebhardt F., Schmidt H., Beckmann A., Hutmacher K., Simon R., et al. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res 60 4 (2000) 854-857
29. Etienne-Grimaldi M.C., Pereira S., Magne N., Formento J.L., Francoual M., Fontana X., et al. Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Ann Oncol 16 6 (2005) 934-941